Patient P-02450

Synthetic patientMETA-24 · Day 178 · 55–64 · M · baseline S12Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

12%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S12
Day 104 NP-02 recommended — Dietary Support Protocol NP-02
Day 105 Patient accepted — Started NP-02 in the companion
Day 115 GI symptom burden −16% vs expected — Dietary Support Protocol NP-02
Day 121 Tolerance state changed — Unstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-11
Toxicity+8
Inflammatory activity+3
Nutritional resilience+3
Treatment adherence+3

What helped?

Dietary Support Protocol NP-02Day 104
Result: symptom burden −16%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

59 min

stable · +0.9 vs previous 14 d

Sleep duration

Wearable

6.3 h

stable · +0.2 vs previous 14 d

Energy level

Daily log

6.6/10

stable · +0.1 vs previous 14 d

Steps

Wearable

5,786

stable · +78 vs previous 14 d

GI burden

Companion

11.6/100

improving · -5.7 vs previous 14 d

Adherence

Companion

93.1 %

stable · -1.1 vs previous 14 d

Sleep quality

Wearable

45.3/100

improving · +3.9 vs previous 14 d

Glucose, CGM daily mean

CGM

136 mg/dL

stable · -5.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 98 from the failing basin, 16 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -2.3 next day on high-intake days · n 19

Would not help

Keep alcohol low
GI +2.6 next day on high-intake days · n 15

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+2.6detractor · 94%
Protein
-2.3supporter · 69%
Dietary fat load
-1.2no signal · 24%
Caffeine
-0.9no signal · 34%
Simple carbohydrates
-0.7no signal · 22%
Insoluble fibre
+0.7no signal · 23%
Histamine load
-0.6no signal · 17%
Ultra-processed food
-0.6no signal · 22%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion
Autonomic recovery ↓20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Intermediate metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 3.2 · butyrate capacity 61/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 55 ms
Sleep: 6.4 h
Steps: 5,509
Resting HR: 59 bpm

Daily log: GI score 12, nutritional resilience 66, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02277	51%	S05	AD-05	improved	92
P-02555	46%	S01	AD-05	no change	79
P-02013	48%	S14	BR-03	no change	94
P-02282	46%	S01	BR-03	no change	88
P-02193	44%	S11	CR-01	improved	87
P-02354	29%	S01	CR-01	improved	78
P-02081	48%	S20	DT-01	no change	88
P-02337	44%	S18	DT-01	no change	100
P-02249	43%	S09	DT-01	improved	100
P-02565	39%	S09	DT-01	no change	79
P-02462	29%	S12	DT-01	improved	65
P-02518	29%	S17	DT-01	improved	68